Centiva Capital’s Neuraxis NRXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Sell
37,526
-13,307
-26% -$98.2K ﹤0.01% 1224
2026
Q1
$376K Buy
+50,833
New +$278K ﹤0.01% 966

Other funds holding NRXS

Centiva Capital's NRXS Position: Q2 2026 in Review

Centiva Capital reduced its Neuraxis (NRXS) stake by 26% in Q2 2026, selling an estimated $98.2K and leaving 37,526 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #1224.

Centiva Capital first reported a position in NRXS in Q1 2026 and has held it in 2 quarters since. The position peaked at $376K in Q1 2026. 32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

  • Centiva Capital held 37,526 shares of Neuraxis worth $274K as of Q2 2026.
  • Centiva Capital sold 13,307 Neuraxis shares in Q2 2026, an estimated $98.2K.
  • Neuraxis made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1224 holding.
  • Centiva Capital first reported a position in Neuraxis in Q1 2026 and has held it in 2 quarters since.
  • Centiva Capital's Neuraxis position peaked at $376K in Q1 2026.
  • 32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.